907

COST-EFFECTIVENESS OF A RIDESHARE PROGRAM TO PROMOTE FOLLOW-UP COLONOSCOPY COMPLETION

Date
May 20, 2024

Introduction: Transportation is a common barrier that limits patient access to colonoscopy, especially in safety-net healthcare systems. Screening for colorectal cancer (CRC) using a fecal immunochemical test (FIT) is cost effective but relies on colonoscopy completion after abnormal FIT results. Our preliminary research found that a rideshare non-emergency transportation (NEMT) intervention was safe, acceptable, and feasible to implement in a safety-net population that required sedation for colonoscopy completion. This study aims to determine the cost-effectiveness of providing rideshare to patients with abnormal FIT results to inform a potential Centers for Medicare and Medicaid Services (CMS) coverage decision for similar rideshare interventions.

Methods: We used the CRC-SPIN microsimulation model to project outcomes (number of CRC cases, deaths and life years) per 1000 people screened and costs associated with improved completion of follow-up colonoscopy after an abnormal FIT result. To examine age effects, we simulated five single-age cohorts (45, 55, 65, 70 or 75 at intervention), that we assumed were adherent to annual FIT screening with a baseline follow-up colonoscopy completion of 35% (no intervention). We determined the change in CRC outcomes if rideshare led to increases in follow-up colonoscopy completion, ranging from 40% to 100%. We also determined the lifetime cost of the intervention at an average ride cost of $40 and $100.

Results: Assuming a screening population of 45-year-olds, a rideshare intervention that increased colonoscopy completion by 15% (35% to 50%) would reduce CRC cases/1000 by 14.4% (35.59 vs. 41.58) and CRC deaths/1000 by 18.2% (11.95 vs. 14.60), resulting in 129,746 life years gained (LYG)/1000. At $100 per ride, the intervention would save $195,456/1000 people screened, with a direct lifetime cost of $11,539/1000 screened. If the rideshare intervention doubled colonoscopy completion in the same population (to 70%), this would reduce CRC cases/1000 by 26.3% (30.65 vs. 41.58), CRC deaths/1000 by 37.3% (9.16 vs. 14.60) and would result in 241,909 LYG/1000. Despite the decreased magnitude of benefit with age, costs also decreased with age and the intervention remained cost-saving for all age-cohorts (Figures 1 & 2).

Conclusions: Increasing colonoscopy completion in a population with abnormal FIT results via a rideshare NEMT intervention is cost-saving at either $40 or $100/ride due to the combined effect of detecting pre-cancerous lesions and CRC at an earlier stage. Rideshare NEMT is a potentially scalable intervention to improve colonoscopy completion after abnormal non-invasive screening tests, a persistent challenge in CRC screening, and should be considered in future CMS coverage decisions.
<b>Figure 1:</b> Colorectal cancer cases and deaths per 1000 people screened by varying adherence to colonoscopy completion after abnormal fecal immunochemical test (FIT) results

Figure 1: Colorectal cancer cases and deaths per 1000 people screened by varying adherence to colonoscopy completion after abnormal fecal immunochemical test (FIT) results

<b>Figure 2</b>: Net lifetime costs for colorectal cancer screening including a rideshare intervention to improve colonoscopy completion after abnormal fecal immunochemical test (FIT) results at $40/ride or $100/ride

Figure 2: Net lifetime costs for colorectal cancer screening including a rideshare intervention to improve colonoscopy completion after abnormal fecal immunochemical test (FIT) results at $40/ride or $100/ride

Presenter

Speaker Image for Rachel Issaka
Fred Hutchinson Cancer Center

Speakers


Tracks

Related Products

Thumbnail for CHARACTERISTICS OF A COST-EFFECTIVE BLOOD TEST FOR COLORECTAL CANCER SCREENING
CHARACTERISTICS OF A COST-EFFECTIVE BLOOD TEST FOR COLORECTAL CANCER SCREENING
Blood-based biomarker tests have been developed as a non-invasive colorectal cancer (CRC) screening method to triage patients to colonoscopy…
Thumbnail for STATE OF THE ART LECTURE
STATE OF THE ART LECTURE
Attendees should attend this session to learn about practical examples of successful quality improvement projects for integration into their day to day work lives. This session will also provide guidance on how to develop a quality improvement project…
Thumbnail for Optimizing Screening Efforts for Colorectal Cancer
Optimizing Screening Efforts for Colorectal Cancer
SOCIETY: AGA CRC screening, disparities